Category: Top Story
-
Pediatrix Medical Group Shares Jump Over 10% After Strong Q3 Earnings Beat Expectations
Pediatrix Medical Group, Inc. (NYSE:MD) shares surged 10.4% on Monday after the physician services provider reported third-quarter results that comfortably exceeded Wall Street estimates, boosted by robust collection activity and an increase in patient acuity levels. The company posted adjusted earnings per share of $0.67, outperforming the consensus estimate of $0.47 by 20 cents. Revenue…
-
Currenc Shares Surge 25% Following Planned Reverse Merger with Animoca Brands
Currenc Group Inc. (NASDAQ:CURR) shares skyrocketed 25% on Monday after the fintech company announced plans for a reverse merger with Animoca Brands Corporation Limited, a global leader in digital assets and blockchain innovation. The deal would create what the two firms describe as “the world’s first publicly listed digital assets conglomerate” on the Nasdaq exchange.…
-
FuboTV Shares Climb as Strong Q3 Results Deliver Profit and Beat Expectations
FuboTV Inc. (NYSE:FUBO) shares rose 5.3% on Monday after the sports-centric streaming platform reported third-quarter results that exceeded Wall Street expectations, including a surprise adjusted profit and higher-than-expected revenue, highlighting its ongoing subscriber momentum. The company posted a loss of $0.06 per share, outperforming analyst projections of a $0.09 loss, while revenue reached $377.2 million,…
-
Alvotech Shares Slide After FDA Requests Further Action on Simponi Biosimilar
Shares of Alvotech (NASDAQ: ALVO) fell 22% on Monday after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s proposed biosimilar to Simponi. The FDA stated that deficiencies identified during a pre-license inspection of Alvotech’s Reykjavik, Iceland, manufacturing facility in July 2025 must be addressed before the Biologics…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street Set to Open Higher as Nvidia Strengthens Tech Momentum
U.S. stock futures were pointing to a higher open on Monday, suggesting Wall Street may build on last week’s positive momentum as strong gains in Nvidia (NASDAQ:NVDA) lift sentiment across the technology sector. The AI chipmaker climbed 2.2% in premarket trading after Microsoft (NASDAQ:MSFT) confirmed it had received export licenses from the Trump administration to…
-
Kontoor Brands Beats Q3 Profit Forecasts and Lifts Full-Year Guidance
Kontoor Brands, Inc. (NYSE:KTB) reported third-quarter earnings that surpassed expectations on Monday, as strong execution and an expanded brand portfolio helped offset a modest revenue miss. The company also raised its full-year outlook, citing continued momentum across key categories. The parent of Wrangler, Lee, and Helly Hansen posted adjusted earnings of $1.44 per share, topping…
-
Caribou Biosciences Shares Double After Strong Multiple Myeloma Trial Results
Caribou Biosciences Inc. (NASDAQ:CRBU) shares skyrocketed 100% on Monday after the company released promising Phase 1 clinical data for its CB-011 therapy in patients with relapsed or refractory multiple myeloma. The CRISPR-based genome-editing company reported a 92% overall response rate and a 75% complete response rate or better among 12 patients treated with the recommended…
-
Stardust Power Shares Jump 15% After Securing Long-Term U.S. Lithium Supply Deal
Stardust Power Inc. (NASDAQ:SDST) shares soared 15% on Monday after the company announced a strategic supply agreement with Mandrake Resources Limited, ensuring access to 7,500 metric tons per year of lithium chloride from Mandrake’s Utah Lithium Project. The companies signed a non-binding Letter of Intent outlining a 12-year supply arrangement with an optional six-year extension,…
-
BioNTech Shares Climb as Strong Revenue Growth Offsets Profit Miss
BioNTech SE (NASDAQ:BNTX) shares rose 2.9% on Monday after the German biotech firm reported third-quarter revenue that far exceeded expectations, even though it posted a loss where analysts had forecast a profit. The company also raised its full-year 2025 revenue outlook, citing stronger-than-expected results from its collaboration with Bristol Myers Squibb (NYSE:BMY). For the third…
-
Kenvue Shares Soar 22% After $48.7 Billion Merger Deal With Kimberly-Clark
Kenvue (NYSE:KVUE) shares surged more than 22% in premarket trading Monday after the U.S. consumer health company reported better-than-expected third-quarter results and revealed plans to be acquired by Kimberly-Clark (NASDAQ:KMB) in a $48.7 billion cash-and-stock deal. For the third quarter, Kenvue earned $0.28 per share, topping analyst estimates of $0.26, while revenue came in at…